Elanco enters agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle
Tuesday, February 25, 2025 • 3 PM
Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based Medgene to leverage the company’s innovative vaccine platform technology.
